GPNX
NOTIFICATION PROCESSED BY IB
21/01/2024
Voltar para busca
Dado oficial do USPTO
FUCASO
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
FUCASO
ST13
US500000079360485Classe
5, 35, 42, 44
Pedido
79360485
Registro
7227099
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
16
Atualização mais recente
21/01/2024
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 35, 42, 44
Data de depósito
20/10/2022
Data de registro
28/11/2023
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
28/11/2023
Última transação
28/11/2023
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
CN
Examinador
BLAZICH,JOAN MICHELE
Unidade examinadora
N40
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Nanjing IASO Medical Technology Co., Ltd.
Representantes
Unitalen Attorneys At Law
Classificação técnica
Classes Nice
Classe 5Classe 35Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; biological preparations for the treatment of cancer; pharmaceutical products for the prevention and treatment of cancer; pharmaceutical products for the treatment of cancer; cytostatics for medical purposes; pharmaceutical preparations for the treatment of immune system related diseases and disorders; diagnostic preparations for medical purposes; biological preparations for the treatment of immune system related disorders; pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; medicines for the treatment of cardiovascular and cerebrovascular diseases; pharmaceutical preparations for peripheral nervous system; pharmaceutical preparations for use in chemotherapy; biological preparations for the treatment of tumor; pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; tumor suppressing agents; pharmaceutical preparations for suppressing tumors; diagnostic biomarker reagents for medical purposes
Classe 35
Advertising services; assistance in franchised commercial business management; import-export agency services; sales promotion for others; retail store services for pharmaceutical, veterinary and sanitary preparations and medical supplies; wholesale store services for pharmaceutical, veterinary and sanitary preparations and medical supplies; retail drug store services
Classe 42
Technological research in the field of medicine; technical research in the field of pharmaceutical studies; research and development of new products for others; scientific laboratory services; medical laboratory services; pharmaceutical research services; biomedical research services; research and development services in the field of antibodies; pharmaceutical research and development; biotechnology research; research on the subject of pharmaceuticals
Classe 44
Performing diagnosis of diseases; medication counseling; medical consultations; consulting services in the field of health; medical services; providing cancer screening services; genetic testing for medical purposes; medical analysis for the diagnosis and treatment of persons; medical services relating to the removal, treatment and processing of human blood
Publicações
Histórico de despachos e eventos da marca no USPTO.
16 publicações encontradas
FICS
FINAL DISPOSITION NOTICE SENT TO IB
04/01/2024
FIMP
FINAL DISPOSITION PROCESSED
04/01/2024
GPAR
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
28/12/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
28/11/2023
GPNX
NOTIFICATION PROCESSED BY IB
18/09/2023
PUBO
PUBLISHED FOR OPPOSITION
12/09/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
30/08/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
30/08/2023
NPUB
NOTICE OF PUBLICATION
23/08/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/08/2023
DOCK
ASSIGNED TO EXAMINER
04/08/2023
MAFR
APPLICATION FILING RECEIPT MAILED
01/02/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
28/01/2023
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
23/01/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
19/01/2023
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace FUCASO ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.